GeminIQ Website Logo

Viewing UTHR free

Subscribe for full history, 90+ metrics, screener, watchlist...

UNITED THERAPEUTICS Corp

UTHR

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
1,8031,2801,5571,3401,5931,9001,6971,5541,3561,2521,2081,108
Marketable Securities Current
8598741,3631,4281,4561,4211,5701,7731,6161,4561,7861,768
Accounts Receivable Net Current
310312350298379322279342291307279259
Inventory Net
194178183177169165158147137120112104
Other Assets Current
317228249252230131170185221113166221
Assets Current
3,4842,8723,7033,4943,8273,9403,8744,0003,6203,2493,5513,459
Marketable Securities Noncurrent
1,1411,3171,7771,5671,9181,7111,4751,2791,3301,4921,9102,061
Intangible Assets Net Including Goodwill
11411611711711211211211211511511444
Property Plant And Equipment Net
1,9301,8411,7301,5561,3621,3031,2221,1571,0951,0741,045992
Deferred Income Tax Assets Net
312335358355456457458391396396395326
Other Assets Noncurrent
240233197263233222222184168169152142
Assets
7,2206,7147,8807,3517,9087,7447,3647,1236,7236,4957,1677,024
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
498498488468432367345364325305298333
Lines Of Credit Current
--000200300400400400400300
Other Liabilities Current
1101017378951559480781267170
Liabilities Current
608599561546527722738873832861804744
Other Liabilities Noncurrent
21221422321520721518214994977867
Liabilities
8208137847617349379201,0221,0261,1571,1821,312
Long Term Line Of Credit
------00100200300500
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
111111111111
Additional Paid In Capital Common Stock
2,8962,5202,7982,6592,7932,7382,6992,6472,5432,4052,5492,524
Accumulated Other Comprehensive Income Loss Net Of…
-16-10100-1-37-15-16-13-44
Treasury Stock Common Value
-5,645-5,442-4,260-4,262-3,475-3,475-3,475-3,475-3,444-3,386-2,579-2,579
Retained Earnings Accumulated Deficit
9,1658,8328,5578,1937,8547,5447,2226,9216,6126,3346,0275,810
Stockholders Equity
6,4005,9017,0966,5907,1746,8076,4446,1015,6975,3385,9855,712
Liabilities And Stockholders Equity
7,2206,7147,8807,3517,9087,7447,3647,1236,7236,4957,1677,024
Allowance For Doubtful Accounts Receivable Current
000000000000
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
245245245245245245245245245245245245
Common Stock Shares Issued
787776767575757574747474
Shares Outstanding
434244434545454544444747
Treasury Stock Common Shares
353533333030303030302727

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-6.69%-9.07%-11.44%---------
20251.50%-4.07%-3.66%10.74%48.10%53.69%4.28%13.58%2.11%-2.02%9.96%6.26%
20246.95%23.87%29.01%11.09%12.68%17.60%3.18%-0.50%-0.68%-1.85%-10.71%-4.25%
2023------3.15%-2.30%-2.78%7.57%6.12%20.57%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
5.73
4.79
6.60
6.40
7.26
5.46
5.25
4.58
4.35
3.77
4.41
4.65
Quick Ratio
5.41
4.50
6.28
6.07
6.94
5.23
5.03
4.41
4.18
3.64
4.28
4.51
Working Capital
2.88B
2.27B
3.14B
2.95B
3.30B
3.22B
3.14B
3.13B
2.79B
2.39B
2.75B
2.71B
Leverage & Debt
Debt to Equity
0.13
0.14
0.11
0.12
0.10
0.14
0.14
0.17
0.18
0.22
0.20
0.23
Interest Coverage TTM
116.82
87.53
76.54
61.46
46.12
39.31
32.10
25.54
22.72
21.37
19.98
19.48
Debt Ratio
0.11
0.12
0.10
0.10
0.09
0.12
0.12
0.14
0.15
0.18
0.16
0.19
Efficiency & Turnover
Asset Turnover TTM
0.42
0.44
0.42
0.43
0.42
0.42
0.40
0.39
0.39
0.39
0.35
0.34
Days Sales Outstanding TTM
39.90
36.50
36.10
37.31
39.73
38.36
35.40
39.76
39.29
32.27
39.15
40.59
Receivables Turnover TTM
9.15
10.00
10.11
9.78
9.19
9.52
10.31
9.18
9.29
11.31
9.32
8.99
Per Share Metrics
Diluted EPS TTM
28.62
27.28
27.86
26.89
25.72
24.91
24.64
22.95
22.51
21.14
19.81
18.10
Free Cash Flow Per Share TTM
25.66
23.38
23.49
25.61
23.75
25.14
23.91
20.14
19.77
16.01
15.97
16.30
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
86.14%
86.58%
87.92%
88.59%
88.98%
89.00%
89.24%
88.94%
88.85%
88.87%
88.94%
88.87%
Operating Profit Margin TTM
44.44%
45.29%
46.89%
47.74%
47.05%
46.88%
47.86%
46.42%
48.28%
50.31%
50.91%
49.92%
Net Profit Margin TTM
41.56%
40.61%
41.94%
40.65%
40.36%
40.44%
41.53%
40.31%
40.87%
42.05%
42.31%
40.82%
Growth Metrics
Net Revenue Growth (1Y)
2.49%
5.87%
10.61%
13.50%
17.62%
19.85%
23.63%
25.04%
23.96%
26.09%
20.20%
18.51%
Net Income Growth (1Y)
5.54%
6.34%
11.68%
14.47%
16.15%
15.25%
21.35%
23.46%
22.71%
44.24%
35.40%
27.20%
EPS Growth (1Y)
11.73%
9.76%
13.95%
16.57%
14.35%
20.64%
25.65%
29.83%
29.62%
42.09%
31.64%
23.40%
Valuation Metrics
P/E TTM
17.61
20.04
16.17
14.44
10.43
11.43
13.34
14.39
13.23
10.28
10.45
11.77
P/B TTM
3.61
4.37
3.04
2.79
1.81
2.03
2.47
2.62
2.48
2.02
1.72
1.85
P/S TTM
7.32
8.14
6.78
5.87
4.21
4.62
5.54
5.80
5.41
4.32
4.42
4.81
Market Cap
23.08B
25.79B
21.59B
18.36B
12.96B
13.84B
15.95B
15.98B
14.14B
10.80B
10.29B
10.59B
Enterprise Value
21.28B
24.51B
20.03B
17.02B
11.37B
12.14B
14.55B
14.83B
13.19B
9.95B
9.48B
9.79B
Calculated Values
Free Cash Flow TTM
1.09B
1.02B
1.04B
1.12B
1.07B
1.13B
1.08B
898.10M
877.90M
752.40M
747.60M
764.30M
Net Debt
-1.80B
-1.28B
-1.56B
-1.34B
-1.59B
-1.70B
-1.40B
-1.15B
-955.70M
-851.50M
-807.70M
-807.70M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-29Sale
Owner: Rothblatt, Martine A
Title: Chairperson & CEO
Shares: 9,500
Price/Share: $544.68
Value: $5,174,460.00
Shares Owned: 40,513
Relationship: Director,Officer
Ownership: Direct
2026-06-26Sale
Owner: Rothblatt, Martine A
Title: Chairperson & CEO
Shares: 9,500
Price/Share: $546.07
Value: $5,187,665.00
Shares Owned: 40,513
Relationship: Director,Officer
Ownership: Direct
2026-06-25Sale
Owner: Rothblatt, Martine A
Title: Chairperson & CEO
Shares: 9,500
Price/Share: $549.56
Value: $5,220,820.00
Shares Owned: 40,513
Relationship: Director,Officer
Ownership: Direct
2026-06-24Sale
Owner: Rothblatt, Martine A
Title: Chairperson & CEO
Shares: 9,500
Price/Share: $549.48
Value: $5,220,060.00
Shares Owned: 40,513
Relationship: Director,Officer
Ownership: Direct
2026-06-23Sale
Owner: Rothblatt, Martine A
Title: Chairperson & CEO
Shares: 9,500
Price/Share: $543.13
Value: $5,159,735.00
Shares Owned: 40,513
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
89.71%
Inst. Shares: 39,023,124
Shares Outstanding: 43,500,000
2025-12-31
88.78%
Inst. Shares: 39,331,495
Shares Outstanding: 44,300,000
2025-09-30
87.84%
Inst. Shares: 38,475,880
Shares Outstanding: 43,800,000
2025-06-30
91.27%
Inst. Shares: 41,163,099
Shares Outstanding: 45,100,000
2025-03-31
90.12%
Inst. Shares: 40,465,899
Shares Outstanding: 44,900,000

UNITED THERAPEUTICS Corp (UTHR) — SEC Financial Statements & Analysis

UNITED THERAPEUTICS Corp (UTHR) is a pharmaceutical preparations company, incorporated in DE. UNITED THERAPEUTICS Corp trades on Nasdaq as: UTHR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), UNITED THERAPEUTICS Corp reported a 2.49% year-over-year revenue growth, a Gross Profit Margin of 86.14% (TTM), a Debt-to-Equity ratio of 0.13x, a Price-to-Sales (P/S) ratio of 7.32x (TTM), a Price-to-Book (P/B) ratio of 3.61x (TTM), at a market cap of $23.08B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
2.49%
Gross Profit Margin TTM
86.14%
Debt To Equity
0.13x
P/S TTM
7.32x
P/B TTM
3.61x
Market Cap
$23.08B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is UNITED THERAPEUTICS Corp in?

UNITED THERAPEUTICS Corp (UTHR) operates in the Pharmaceutical Preparations industry.

What is UTHR's market cap?

UNITED THERAPEUTICS Corp (UTHR) has a market capitalization of $23.08B as of 2026-06-30.

What is UTHR's P/E ratio?

UNITED THERAPEUTICS Corp (UTHR)'s trailing twelve month P/E ratio is 17.61x as of 2026-06-30.

What exchange does UTHR trade on?

UNITED THERAPEUTICS Corp (UTHR) trades on the Nasdaq.

Where is UNITED THERAPEUTICS Corp incorporated?

UNITED THERAPEUTICS Corp is incorporated in DE.

Wall Street's data.
Main Street's price.